GEP19991861B - Radiolabeled Platelet GPIIb/IIIa Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
- Google Patents
Radiolabeled Platelet GPIIb/IIIa Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
Info
Publication number
GEP19991861B
GEP19991861BGEAP19942898AGEAP1994002898AGEP19991861BGE P19991861 BGEP19991861 BGE P19991861BGE AP19942898 AGEAP19942898 AGE AP19942898AGE AP1994002898 AGEAP1994002898 AGE AP1994002898AGE P19991861 BGEP19991861 BGE P19991861B
Authority
GE
Georgia
Prior art keywords
diagnosis
receptor antagonists
imaging agents
thromboembolic disorders
iiia receptor
Prior art date
Application number
GEAP19942898A
Inventor
Milind Rajopadhye
Thomas David Harris
David Scott Edwards
John Andrew Barett
Michael Sworin
Shaker Ahmed Mousa
William Frank Degrado
Original Assignee
Du Pont Pharmaceuticals Co
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharmaceuticals Co, American Home ProdfiledCriticalDu Pont Pharmaceuticals Co
Publication of GEP19991861BpublicationCriticalpatent/GEP19991861B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Increase in diagnostic accuracy. 2. Essence Radiopharmaceuticals represent radio-labeled cyclic compounds containing carbocyclic or heterocyclic ring systems. 3. Field of Application Medicine. 8 ind. cl., 62 dep. cl., 2 fig.
GEAP19942898A1993-03-301994-03-29Radiolabeled Platelet GPIIb/IIIa Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
GEP19991861B
(en)
2,2-DIMETHYLCHROMAN-3-OL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL AGENTS